Table of Contents
2019-2024 Global OTC Anti-Infective Products Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global OTC Anti-Infective Products Consumption 2014-2024
2.1.2 OTC Anti-Infective Products Consumption CAGR by Region
2.2 OTC Anti-Infective Products Segment by Type
2.2.1 Antifungals
2.2.2 Antiseptic
2.2.3 Antiparasitics
2.3 OTC Anti-Infective Products Consumption by Type
2.3.1 Global OTC Anti-Infective Products Consumption Market Share by Type (2014-2019)
2.3.2 Global OTC Anti-Infective Products Revenue and Market Share by Type (2014-2019)
2.3.3 Global OTC Anti-Infective Products Sale Price by Type (2014-2019)
2.4 OTC Anti-Infective Products Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Drug Stores
2.4.3 Retail Stores
2.4.4 E-Commerce
2.5 OTC Anti-Infective Products Consumption by Application
2.5.1 Global OTC Anti-Infective Products Consumption Market Share by Application (2014-2019)
2.5.2 Global OTC Anti-Infective Products Value and Market Share by Application (2014-2019)
2.5.3 Global OTC Anti-Infective Products Sale Price by Application (2014-2019)
3 Global OTC Anti-Infective Products by Players
3.1 Global OTC Anti-Infective Products Sales Market Share by Players
3.1.1 Global OTC Anti-Infective Products Sales by Players (2017-2019)
3.1.2 Global OTC Anti-Infective Products Sales Market Share by Players (2017-2019)
3.2 Global OTC Anti-Infective Products Revenue Market Share by Players
3.2.1 Global OTC Anti-Infective Products Revenue by Players (2017-2019)
3.2.2 Global OTC Anti-Infective Products Revenue Market Share by Players (2017-2019)
3.3 Global OTC Anti-Infective Products Sale Price by Players
3.4 Global OTC Anti-Infective Products Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global OTC Anti-Infective Products Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players OTC Anti-Infective Products Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 OTC Anti-Infective Products by Regions
4.1 OTC Anti-Infective Products by Regions
4.1.1 Global OTC Anti-Infective Products Consumption by Regions
4.1.2 Global OTC Anti-Infective Products Value by Regions
4.2 Americas OTC Anti-Infective Products Consumption Growth
4.3 APAC OTC Anti-Infective Products Consumption Growth
4.4 Europe OTC Anti-Infective Products Consumption Growth
4.5 Middle East & Africa OTC Anti-Infective Products Consumption Growth
5 Americas
5.1 Americas OTC Anti-Infective Products Consumption by Countries
5.1.1 Americas OTC Anti-Infective Products Consumption by Countries (2014-2019)
5.1.2 Americas OTC Anti-Infective Products Value by Countries (2014-2019)
5.2 Americas OTC Anti-Infective Products Consumption by Type
5.3 Americas OTC Anti-Infective Products Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC OTC Anti-Infective Products Consumption by Countries
6.1.1 APAC OTC Anti-Infective Products Consumption by Countries (2014-2019)
6.1.2 APAC OTC Anti-Infective Products Value by Countries (2014-2019)
6.2 APAC OTC Anti-Infective Products Consumption by Type
6.3 APAC OTC Anti-Infective Products Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe OTC Anti-Infective Products by Countries
7.1.1 Europe OTC Anti-Infective Products Consumption by Countries (2014-2019)
7.1.2 Europe OTC Anti-Infective Products Value by Countries (2014-2019)
7.2 Europe OTC Anti-Infective Products Consumption by Type
7.3 Europe OTC Anti-Infective Products Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa OTC Anti-Infective Products by Countries
8.1.1 Middle East & Africa OTC Anti-Infective Products Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa OTC Anti-Infective Products Value by Countries (2014-2019)
8.2 Middle East & Africa OTC Anti-Infective Products Consumption by Type
8.3 Middle East & Africa OTC Anti-Infective Products Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 OTC Anti-Infective Products Distributors
10.3 OTC Anti-Infective Products Customer
11 Global OTC Anti-Infective Products Market Forecast
11.1 Global OTC Anti-Infective Products Consumption Forecast (2019-2024)
11.2 Global OTC Anti-Infective Products Forecast by Regions
11.2.1 Global OTC Anti-Infective Products Forecast by Regions (2019-2024)
11.2.2 Global OTC Anti-Infective Products Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global OTC Anti-Infective Products Forecast by Type
11.8 Global OTC Anti-Infective Products Forecast by Application
12 Key Players Analysis
12.1 GlaxoSmithKline
12.1.1 Company Details
12.1.2 OTC Anti-Infective Products Product Offered
12.1.3 GlaxoSmithKline OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 GlaxoSmithKline News
12.2 Merck
12.2.1 Company Details
12.2.2 OTC Anti-Infective Products Product Offered
12.2.3 Merck OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Merck News
12.3 Pfizer
12.3.1 Company Details
12.3.2 OTC Anti-Infective Products Product Offered
12.3.3 Pfizer OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Pfizer News
12.4 Novartis
12.4.1 Company Details
12.4.2 OTC Anti-Infective Products Product Offered
12.4.3 Novartis OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Novartis News
12.5 Abbott
12.5.1 Company Details
12.5.2 OTC Anti-Infective Products Product Offered
12.5.3 Abbott OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Abbott News
12.6 Sanofi
12.6.1 Company Details
12.6.2 OTC Anti-Infective Products Product Offered
12.6.3 Sanofi OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Sanofi News
12.7 Bristol-Myers Squibb
12.7.1 Company Details
12.7.2 OTC Anti-Infective Products Product Offered
12.7.3 Bristol-Myers Squibb OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Bristol-Myers Squibb News
12.8 Roche
12.8.1 Company Details
12.8.2 OTC Anti-Infective Products Product Offered
12.8.3 Roche OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Roche News
12.9 NanoViricides
12.9.1 Company Details
12.9.2 OTC Anti-Infective Products Product Offered
12.9.3 NanoViricides OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 NanoViricides News
12.10 Novabay Pharmaceuticals
12.10.1 Company Details
12.10.2 OTC Anti-Infective Products Product Offered
12.10.3 Novabay Pharmaceuticals OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Novabay Pharmaceuticals News
12.11 Optimer Pharmaceuticals
12.12 Basilea Pharmaceutica
12.13 MerLion Pharma
13 Research Findings and Conclusion
